Thrombin, a mediator of neurotoxicity and memory impairment
Thrombin, a mediator of neurotoxicity and memory impairment
复制标题
DOI:
10.1016/j.neurobiolaging.2003.07.007
复制
发表时间:
2004-07-01
影响因子:
4.2
通讯作者:
Grammas, P
中科院分区:
文献类型:
--
作者:
Mhatre, M;Nguyen, A;Grammas, P
Thrombin has been found in neuritic plaques in Alzheimer's disease (AD). Also, traumatic brain injury, where neurons are exposed to high thrombin levels, is associated with an increased incidence of AD. Our objective was to determine the effects of thrombin administered in vivo on cognitive function and neuropathology. Rats were trained using a radial eight-arm maze and then thrombin (25 or 100 nM, 0.25 mu/h, 28 days) or vehicle was delivered via intracerebroventricular infusion. Animals that received 100 nM thrombin demonstrated cognitive impairments including deficits in reference memory and an increase in task latency. Also, significant neuropathology was detected in these animals such as enlargement of cerebral ventricles, an increased number of TUNEL-positive cells, astrogliosis, and an increase in the immumoreactivity for phosphorylated neurofilament, and apolipoprotein-E fragments. Thrombin-induced changes in cognitive function and ventricular enlargement were inhibited by hirudin. These findings demonstrate that thrombin is a mediator of neurotoxicity and cognitive deficits and suggest that inhibition of thrombin may be a treatment strategy for AD- or head trauma-associated cognitive deficits. (C) 2003 Elsevier Inc. All rights reserved.